| thrombosis prevention | UFH | not classified | versus heparin No demonstrated result for efficacy | 4 trials | meta-analysis | | | Trial | control | p<0.05 | harm | NS |
|---|
| Wille-Jorgensen, 1991 | GCS + UFH vs UFH | DVT (asymptomatic or symptomatic) 0.17 [0.04; 0.72] | | PE 0.00 [0.00; NaN] | | Wille-Jorgensen, 1985 | GCS + UFH vs UFH | DVT (asymptomatic or symptomatic) 0.19 [0.04; 0.83] | | | | *Rasmussen (adj), 1988 | GCS + UFH vs UFH | | | DVT (asymptomatic or symptomatic) 0.88 [0.54; 1.42] | | Torngren, 1980 | GCS + UFH vs UFH | DVT (asymptomatic or symptomatic) 0.33 [0.11; 0.99] | | |
| Trial | Treatments | Patients | Method |
|---|
| Wille-Jorgensen, 1991 | low dose heparin and graded compression stockings (n=83) vs. low dose heparin (n=83) | patients undergoing Abdominal surgery | parallel groups Sample size: 83/83 Primary endpoint: FU duration: | | Wille-Jorgensen, 1985 | low-dose heparin treatment with graded compression stockings (n=86) vs. low-dose heparin treatment (5000 units twice daily subcutaneously) (n=90) | patients undergoing Abdominal surgery | parallel groups Sample size: 86/90 Primary endpoint: FU duration: | | *Rasmussen (adj), 1988 | subcutaneous heparin and graduated compression stockings to the knee (TED stockings), (n=-9) vs. subcutaneous heparin (n=-9) | patients (age more than 40 yrs) admitted for major abdominal surgery | open Parallel groups Sample size: -9/-9 Primary endpoint: FU duration: | | Torngren, 1980 | (n=-9) vs. (n=-9) | | Sample size: -9/-9 Primary endpoint: FU duration: |
|
